- Home
- XAIR vs ALUR Comparison
XAIR vs ALUR Comparison
Compare XAIR & ALUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XAIR
- ALUR
- Stock Information
- Founded
- XAIR 2011
- ALUR 2009
- Country
- XAIR United States
- ALUR United States
- Employees
- XAIR N/A
- ALUR N/A
- Industry
- XAIR Medical/Dental Instruments
- ALUR
- Sector
- XAIR Health Care
- ALUR
- Exchange
- XAIR Nasdaq
- ALUR Nasdaq
- Market Cap
- XAIR 26.0M
- ALUR 22.5M
- IPO Year
- XAIR N/A
- ALUR N/A
- Fundamental
- Price
- XAIR $0.42
- ALUR $2.93
- Analyst Decision
- XAIR Strong Buy
- ALUR Strong Buy
- Analyst Count
- XAIR 4
- ALUR 4
- Target Price
- XAIR $3.67
- ALUR $75.00
- AVG Volume (30 Days)
- XAIR 2.3M
- ALUR 87.7K
- Earning Date
- XAIR 02-10-2025
- ALUR 11-13-2024
- Dividend Yield
- XAIR N/A
- ALUR N/A
- EPS Growth
- XAIR N/A
- ALUR N/A
- EPS
- XAIR N/A
- ALUR N/A
- Revenue
- XAIR $2,342,000.00
- ALUR $34,754,000.00
- Revenue This Year
- XAIR $230.80
- ALUR N/A
- Revenue Next Year
- XAIR $265.55
- ALUR $2.22
- P/E Ratio
- XAIR N/A
- ALUR N/A
- Revenue Growth
- XAIR 685.91
- ALUR N/A
- 52 Week Low
- XAIR $0.30
- ALUR $2.37
- 52 Week High
- XAIR $2.17
- ALUR $98.75
- Technical
- Relative Strength Index (RSI)
- XAIR 51.29
- ALUR 27.81
- Support Level
- XAIR $0.34
- ALUR $2.72
- Resistance Level
- XAIR $0.38
- ALUR $4.20
- Average True Range (ATR)
- XAIR 0.06
- ALUR 1.92
- MACD
- XAIR 0.00
- ALUR -0.52
- Stochastic Oscillator
- XAIR 40.62
- ALUR 4.95
About XAIR Beyond Air Inc.
Beyond Air Inc is a commercial-stage medical device and biopharmaceutical company that develops a Nitric Oxide (NO) Generator and Delivery System that uses NO generated from ambient air and delivers precise amounts of NO to the lungs for the potential treatment of respiratory and other diseases. The firm is applying its therapeutic expertise to develop treatments for pulmonary hypertension, in addition to treatments for lower respiratory tract infections.
About ALUR Allurion Technologies Inc.
Allurion Technologies Inc is a medical device company that focuses on creating a best-in-class weight loss platform to treat overweight patients. Its platform, the Allurion Program, features the world's first and only swallowable, procedure-less intragastric balloon for weight loss and offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion VCS. Its proprietary intragastric balloon, the Allurion Balloon, is in the form of a swallowed capsule that is administered to patients under the guidance of a healthcare provider without surgery, endoscopy, or anesthesia.